Asian Journal of Case Reports in Surgery

A Rare Case of Primary Neuroendocrine Tumor of the Bladder

Suruchi Kumari *

Department of General Surgery, LHMC, New Delhi, India.

Manoj Andley

Department of General Surgery, LHMC, New Delhi, India.

Sudipta Saha

Department of General Surgery, LHMC, New Delhi, India.

Katyayni Singh

Department of General Surgery, LHMC, New Delhi, India.

Sumanth Reddy

Department of General Surgery, LHMC, New Delhi, India.

*Author to whom correspondence should be addressed.

---

Abstract

We present the case of a 45-year-old gentleman who presented with gross hematuria and underwent radical cystectomy, leading to an unexpected post-operative diagnosis of primary neuroendocrine tumor of the urinary bladder. This case underscores the diagnostic challenges associated with this rare malignancy and emphasizes the importance of considering neuroendocrine tumors in the differential diagnosis of bladder neoplasms. We discuss the clinical presentation, diagnostic workup, surgical intervention, and post-operative management of this unique case.

Keywords: Neuroendocrine tumor, bladder neoplasms, urothelial carcinomas, radical cystectomy

---

---

---

References

Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG. Radical cystectomy for primary neuroendocrine tumors of the bladder: the University of Southern California experience. The Journal of urology. 2005;174(1):93-6.

Evans AJ, Al-Maghrabi J, Tsihlias J, Lajoie G, Sweet JM, Chapman WB. Primary large cell neuroendocrine carcinoma of the urinary bladder. Archives of pathology & laboratory medicine. 2002;126(10):1229-32.

Mazzucchelli R, Morichetti D, Lopez-Beltran A, et al. Neuroendocrine tumors of the urinary system and male genital organs: clinical significance. BJU Int. 2009;103:1464–1470.

Willis DL, Porten SP, Kamat AM. Should histologic variants alter definitive treatment of bladder cancer? Curr Opin Urol. 2013;23(5):435–443.

Siefker-Radtke AO, Dinney CP, Abrahams NA, et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M.D. Anderson cancer experience. J Urol. 2004;172(2):481– 484.

Siefker-Radtke AO, Kamat AM, Grossman HB, et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol 2009;27: 2592-2597.

McGregor BA, Campbell MT, Xie W, et al. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer 2021;127:840-849.

Ismaili N, Elkarak F, Heudel PE, Flechon A, Droz JP. Small cell cancer of the bladder:The Leon-Berard cancer centre experience. Indian J Urol. 2008;24: 494–7.

Bellmunt J, Orsola A, Wiegel T, Guix M, De Santis M, Kataja V, et al. Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22(Suppl 6):i45–9.

Sved P, Gomez P, Manoharan M, Civantos F, Soloway MS. Small cell carcinoma of the bladder. BJU Int. 2004; 94:12–7.